Phillip E. Lee - 16 Dec 2022 Form 4 Insider Report for Vaxart, Inc. (VXRT)

Role: Chief Financial Officer
Signature: /s/ Edward Berg, Attorney-in-Fact for W. Mark Watson
Issuer symbol: VXRT
Transactions as of: 16 Dec 2022
Net transactions value: $0
Form type: 4
Filing time: 30 Dec 2022, 19:21:25 UTC
Previous filing: 30 Dec 2022
Next filing: 11 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VXRT	Common Stock	Award	$0	+68,750		$0.000000	68,750	16 Dec 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VXRT	Stock Option (Right to Buy)	Award	$0	+412,500		$0.000000	412,500	16 Dec 2022	Common Stock	412,500	$1.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of shares upon vesting of restricted stock units ("RSUs"). The RSUs vest as to 25% of the shares underlying the award on each anniversary of December 15, 2022 (the "Start Date"), so that the RSUs would be fully vested on the fourth anniversary of the Start Date.
F2	The shares subject to this stock option shall vest as to 25% of the shares underlying the grant on December 15,2023, the first anniversary of the Start Date, and thereafter in 36 equal monthly installments such that the stock option shall be fully vested on December 16, 2026.